VCP
SMED

Verus Capital Partners’s Sharps Compliance Corp SMED Stock Holding History

Verus Capital Partners’s Portfolio SMED Stock Details SMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$2K Buy
+200
New +$1.03K ﹤0.01% 1369

Other funds holding SMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
GIPM
G2 Investment Partners Management New York $406M AUM 164.47% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CCM
Cadence Capital Management Boston, Massachusetts $415M AUM 11.01% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Verus Capital Partners's SMED Position: Q1 2020 in Review

Verus Capital Partners opened a new position in Sharps Compliance Corp (SMED) in Q1 2020: 200 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1369 among its holdings.

43 funds tracked by Wall St. Rank hold SMED as of Q1 2020.

  • Verus Capital Partners held 200 shares of Sharps Compliance Corp worth $2K as of Q1 2020.
  • Sharps Compliance Corp was a new Verus Capital Partners position in Q1 2020.
  • Sharps Compliance Corp made up ﹤0.01% of Verus Capital Partners's portfolio in Q1 2020, its #1369 holding.
  • 43 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q1 2020.

Based on Verus Capital Partners's 13F filing for Q1 2020, filed 26 May 2020.